Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04531527Phase 3Completed
A Phase 3 trial of butenafine in fungal skin infection (mycosis), sponsored by Bayer. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04531527.